BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

832 related articles for article (PubMed ID: 4139225)

  • 1. Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
    Theofilopoulos AN; Dixon FJ; Bokisch VA
    J Exp Med; 1974 Oct; 140(4):877-94. PubMed ID: 4139225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of soluble immune complexes to human lymphoblastoid cells. II. Use of Raji cells to detect circulating immune complexes in animal and human sera.
    Theofilopoulos AN; Wilson CB; Bokisch VA; Dixon FJ
    J Exp Med; 1974 Nov; 140(5):1230-44. PubMed ID: 4138539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor for soluble C3 and C3b on human lymphoblastoid (RAJI) cells. Properties and biologocal significance.
    Theofilopoulos AN; Bokisch VA; Dixon FJ
    J Exp Med; 1974 Mar; 139(3):696-711. PubMed ID: 4591176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Raji cell radioimmune assay for detecting immune complexes in human sera.
    Theofilopoulos AN; Wilson CB; Dixon FJ
    J Clin Invest; 1976 Jan; 57(1):169-82. PubMed ID: 128562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative evaluation of receptor reactivities for C3b, iC3b, and C3d on Raji lymphoblastoid cells.
    Scheiner O; Hammann KP; Schmid HU; Schulz T; Alsenz J; Dierich MP
    Int Arch Allergy Appl Immunol; 1982; 69(3):231-7. PubMed ID: 6215359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
    Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
    Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.
    Weis JJ; Tedder TF; Fearon DT
    Proc Natl Acad Sci U S A; 1984 Feb; 81(3):881-5. PubMed ID: 6230668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-binding sites on C3 and C3b.
    Dierich MP; Bokisch VA
    J Immunol; 1977 Jun; 118(6):2145-50. PubMed ID: 864256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte receptors. I. Receptors for Fc of IgG and complement (C3b) on immunoglobulin-bearing, antigen-binding and antibody-secreting cells.
    McConnell I; Hurd CM
    Immunology; 1976 Jun; 30(6):825-33. PubMed ID: 800392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of human lymphocyte complement receptors.
    Ross GD; Polley MJ
    J Exp Med; 1975 May; 141(5):1163-80. PubMed ID: 805205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The covalent interaction of C3 with IgG immune complexes.
    Vivanco F; Muñoz E; Vidarte L; Pastor C
    Mol Immunol; 1999; 36(13-14):843-52. PubMed ID: 10698338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of complement in adherent immune complexes on Fc and C3 receptor expression in human monocytes.
    Arend WP; Massoni RJ
    Immunology; 1981 Dec; 44(4):717-25. PubMed ID: 7319557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human lymphocytes bear membrane receptors for C3b and C3d.
    Eden A; Miller GW; Nussenzweig V
    J Clin Invest; 1973 Dec; 52(12):3239-42. PubMed ID: 4543024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
    Antón LC; Ruiz S; Barrio E; Marqués G; Sánchez A; Vivanco F
    Eur J Immunol; 1994 Mar; 24(3):599-604. PubMed ID: 8125130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.
    Gerdes J; Klatt U; Stein H
    Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A small domain (6.5 kDa) of bacterial protein G inhibits C3 covalent binding to the Fc region of IgG immune complexes.
    Muñoz E; Vidarte L; Pastor C; Casado M; Vivanco F
    Eur J Immunol; 1998 Aug; 28(8):2591-7. PubMed ID: 9710236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity.
    Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1981 Jun; 153(6):1592-603. PubMed ID: 7252421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of components of the properdin system to cultured human lymphoblastoid cells and B lymphocytes.
    Theofilopoulos AN; Perrin LH
    J Exp Med; 1976 Feb; 143(2):271-89. PubMed ID: 1082488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
    Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface receptors on human haematopoietic cell lines.
    Huber C; Sundström C; Nilsson K; Wigzell H
    Clin Exp Immunol; 1976 Sep; 25(3):367-76. PubMed ID: 963908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.